ONC
BeiGene, Ltd.
365.90$
+0.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -4,395.1% | – | – | – | – | – | – | – | |
| – | -0.8% | +23.6% | +149.2% | +118.3% | +79.2% | +70.8% | +46.1% | +42.7% | +32.3% | +95.9% | -17.5% | |
| – | +53.8% | +4.1% | +303.4% | +103.3% | +54.0% | +36.8% | +31.2% | +25.9% | +21.3% | +20.1% | +15.7% | |
| – | – | +524.0% | +305.1% | -130.1% | – | – | -178.6% | – | -379.9% | – | – | |
| – | +712.5% | +342.3% | +149.9% | +139.8% | +12.6% | +44.4% | +37.5% | +49.0% | +27.1% | -11.3% | -64.9% | |
| – | +75.1% | +276.6% | +60.6% | +78.9% | – | -671.7% | – | +68.1% | -94.4% | -1,013.9% | -49.6% | |
| – | -6.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -164.9% | – | -59.8% | -97.4% | |
| – | +97.8% | +269.1% | +28.7% | +244.8% | -94.9% | +5,972.4% | -30.1% | -100.5% | – | -53.6% | +447.7% | |
| – | -60.2% | +1,653.8% | +118.4% | +229.5% | -123.9% | – | +289.1% | -117.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.